title: Genomic medicine for cancer prognosis.
abstract: There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.
authors.affiliation: Endocrine Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287.
authors.forename: Aarti
authors.initials: A
authors.lastname: Mathur
authors.forename: Martha A
authors.initials: MA
authors.lastname: Zeiger
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D023281:Genomics; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor
keywords: BRAF; genomic medicine; prognosis